miR-214-3p, predicted to bind with POLR2J4, showed significant downregulation in HBV–HCC tumor tissues (Figure 3A) and cells (Figure 3B) compared to normal tissues, cells, and non-HBV cells (P < .001). The gene discussed is POLR2J4; the disease is hepatocellular carcinoma.